Bolivia, Plurinational State of vs Malaysia: Antiretroviral therapy coverage
Bolivia, Plurinational State of
60.0%
in 2024
Malaysia
60.0%
in 2024
Bolivia, Plurinational State of rank
106th
Malaysia rank
106th
Antiretroviral therapy coverage over time
- Bolivia, Plurinational State of
- Malaysia
How they compare
Bolivia, Plurinational State of currently reports 60.0% against 60.0% in Malaysia, a difference of 0.0%.
Across all 25 years both countries report, Malaysia has been ahead every year.
Bolivia, Plurinational State of ranks 106th and Malaysia ranks 106th of 143 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 8.8% | 7.2% | Malaysia |
| 2010s | 21.5% | 33.9% | 12.4% | Malaysia |
| 2020s | 52.8% | 57.6% | 4.8% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Bolivia, Plurinational State of or Malaysia?
- Bolivia, Plurinational State of, at 60.0% against 60.0% in Malaysia as of 2024.
- What is the difference in antiretroviral therapy coverage between Bolivia, Plurinational State of and Malaysia?
- 0.0%, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Malaysia?
- 25 years are reported by both, from 2000 to 2024.
- How do Bolivia, Plurinational State of and Malaysia rank globally for antiretroviral therapy coverage?
- Bolivia, Plurinational State of ranks 106th and Malaysia ranks 106th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.